SCHEMBL6497476

SCHEMBL6497476

FC(F)(F)c1cccc(-c2nc3ccccn3n2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 3/20 0.44
AHR P35869 2/20 0.44
LMNA P02545 2/20 0.43
CYP1A2 P05177 2/20 0.43
HPGD P15428 2/20 0.43
GAA P10253 2/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
CYP11B2 P19099 1/20 0.42
JAK2 O60674 1/20 0.42
JAK3 P52333 1/20 0.42
MAPT P10636 1/20 0.41
IDO1 P14902 1/20 0.41
HSD17B10 Q99714 2/20 0.41
DYRK1A Q13627 1/20 0.41
DYRK2 Q92630 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30601254 0.84 AHR (0.61) AHRCYP11B2JAK2JAK3
SCHEMBL30117384 0.83 MAOB (0.40) ALDH1A1KDM4ELMNACYP11B2JAK2
SCHEMBL15170804 0.78 CYP11B2 (0.53) AHRCYP11B2JAK2JAK3
SCHEMBL15558291 0.78 ALDH1A1 (0.49) ALDH1A1KDM4EAHRLMNAHPGD
SCHEMBL30288869 0.78 AHR (0.68) ALDH1A1AHRHPGDHTTKMT2A
SCHEMBL21306345 0.78 PDE10A (0.51) AHRCYP11B2JAK2JAK3ADORA2A
SCHEMBL24638644 0.77 PDE10A (0.50) ALDH1A1AHRHPGDKMT2ACYP11B2
SCHEMBL30601183 0.76 CYP11B2 (0.51) AHRCYP11B2JAK2JAK3
SCHEMBL19041655 0.76 CYP11B2 (0.46) AHRCYP11B2JAK2JAK3
SCHEMBL19041667 0.75 CYP11B2 (0.48) AHRCYP11B2JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP ALDH1A1 1577/4885KDM4E 4402/4885AHR 2535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.